COMPANY NAME |
REVENUES 12 Months Ending Q1 2025 |
MARKET SHARE 12 Months Q1 2025 |
MARKET SHARE MRQ Q1 2025 |
MARKET SHARE A Quarter Before Q4 2024 |
Nanoviricides inc |
0.00 |
0.00% |
0.00 % |
0.00 % |
Johnson and Johnson |
89,331.00 |
14.13% |
14.33% |
13.73% |
Merck and Co Inc |
63,922.00 |
10.11% |
10.16% |
9.53% |
Pfizer Inc |
62,463.00 |
9.88% |
8.97% |
10.83% |
Abbvie Inc |
57,367.00 |
9.08% |
8.73% |
9.21% |
Sanofi |
49,599.72 |
7.85% |
7.85% |
0.00% |
Eli Lilly And Company |
49,003.20 |
7.75% |
8.33% |
8.25% |
Bristol myers Squibb Company |
47,636.00 |
7.54% |
7.33% |
7.53% |
Novartis Ag |
46,660.00 |
7.38% |
7.38% |
0.00% |
Astrazeneca Plc |
45,811.00 |
7.25% |
7.25% |
0.00% |
Takeda Pharmaceutical Company Limited |
29,166.69 |
4.61% |
4.61% |
0.00% |
Gilead Sciences Inc |
28,735.00 |
4.55% |
4.36% |
4.62% |
Regeneron Pharmaceuticals Inc |
14,085.70 |
2.23% |
1.98% |
2.31% |
Vertex Pharmaceuticals Inc |
11,099.70 |
1.76% |
1.81% |
1.78% |
Organon and Co |
6,294.00 |
1.00% |
0.99% |
0.97% |
Jazz Pharmaceuticals Plc |
4,064.81 |
0.64% |
0.59% |
0.66% |
Horizon Therapeutics Public Limited Company |
3,643.45 |
0.58% |
0.62% |
0.51% |
Moderna Inc |
3,177.00 |
0.50% |
0.07% |
0.59% |
United Therapeutics Corporation |
2,994.10 |
0.47% |
0.52% |
0.45% |
Biomarin Pharmaceutical Inc |
2,950.23 |
0.47% |
0.49% |
0.46% |
Adhera Therapeutics Inc |
2,732.01 |
0.43% |
0.00% |
0.00% |
Alnylam Pharmaceuticals Inc |
2,348.10 |
0.37% |
0.39% |
0.36% |
Ptc Therapeutics inc |
900.03 |
0.14% |
0.00% |
0.11% |
Apellis Pharmaceuticals Inc |
775.84 |
0.12% |
0.11% |
0.13% |
Opko Health Inc |
713.14 |
0.11% |
0.12% |
0.11% |
Kiniksa Pharmaceuticals International Plc |
481.17 |
0.08% |
0.09% |
0.07% |
Arvinas Inc |
426.90 |
0.07% |
0.12% |
0.04% |
Innoviva Inc |
408.35 |
0.06% |
0.05% |
0.05% |
Legend Biotech Corporation |
285.14 |
0.05% |
0.05% |
0.00% |
Arrowhead Pharmaceuticals Inc |
278.34 |
0.04% |
0.36% |
0.00% |
Travere Therapeutics Inc |
273.53 |
0.04% |
0.05% |
0.05% |
Galapagos Nv |
268.49 |
0.04% |
0.04% |
0.00% |
Morphosys Ag |
266.87 |
0.04% |
0.04% |
0.00% |
Esperion Therapeutics Inc |
259.57 |
0.04% |
0.04% |
0.04% |
Pharming Group N v |
245.10 |
0.04% |
0.00% |
0.12% |
Amarin Corp Plcuk |
214.11 |
0.03% |
0.03% |
0.04% |
Ligand Pharmaceuticals Incorporated |
181.29 |
0.03% |
0.03% |
0.03% |
Fibrogen Inc |
180.01 |
0.03% |
0.00% |
0.00% |
Cytomx Therapeutics Inc |
147.56 |
0.02% |
0.03% |
0.02% |
Kamada Ltd |
142.52 |
0.02% |
0.02% |
0.00% |
Arcus Biosciences Inc |
141.00 |
0.02% |
0.02% |
0.02% |
Prothena Corporation Public Limited Company |
137.94 |
0.02% |
0.00% |
0.00% |
Bridgebio Pharma Inc |
127.42 |
0.02% |
0.08% |
0.00% |
Xencor Inc |
127.23 |
0.02% |
0.02% |
0.03% |
Gossamer Bio Inc |
124.59 |
0.02% |
0.01% |
0.01% |
Siga Technologies Inc |
120.33 |
0.02% |
0.00% |
0.05% |
Anaptysbio inc |
111.87 |
0.02% |
0.02% |
0.03% |
Zymeworks Inc |
93.38 |
0.01% |
0.02% |
0.02% |
Optinose Inc |
90.62 |
0.01% |
0.02% |
0.01% |
Nektar Therapeutics |
87.25 |
0.01% |
0.01% |
0.02% |
Theratechnologies Inc |
81.76 |
0.01% |
0.01% |
0.00% |
Morphic Holding inc |
75.30 |
0.01% |
0.00% |
0.00% |
Theravance Biopharma inc |
65.27 |
0.01% |
0.01% |
0.01% |
Enanta Pharmaceuticals Inc |
64.46 |
0.01% |
0.01% |
0.01% |
Ocular Therapeutix Inc |
59.65 |
0.01% |
0.01% |
0.01% |
Fortress Biotech Inc |
57.78 |
0.01% |
0.01% |
0.01% |
Alpine Immune Sciences Inc |
56.52 |
0.01% |
0.00% |
0.02% |
Nurix Therapeutics Inc |
56.42 |
0.01% |
0.01% |
0.01% |
Journey Medical Corp |
56.13 |
0.01% |
0.01% |
0.01% |
Integrated Biopharma Inc |
53.38 |
0.01% |
0.01% |
0.01% |
Ideaya Biosciences Inc |
49.87 |
0.01% |
0.00% |
0.00% |
Spero Therapeutics Inc |
44.58 |
0.01% |
0.00% |
0.01% |
Xoma Royalty Corporation |
42.91 |
0.01% |
0.01% |
0.01% |
Scpharmaceuticals Inc |
41.98 |
0.01% |
0.01% |
0.01% |
Cumberland Pharmaceuticals Inc |
41.08 |
0.01% |
0.01% |
0.01% |
Cartesian Therapeutics Inc |
40.01 |
0.01% |
0.00% |
0.00% |
Mirati Therapeutics Inc |
38.19 |
0.01% |
0.01% |
0.01% |
Mereo Biopharma Group Plc |
36.46 |
0.01% |
0.00% |
0.00% |
Lexicon Pharmaceuticals Inc |
31.08 |
0.00% |
0.02% |
0.00% |
Casi Pharmaceuticals inc |
28.54 |
0.00% |
0.00% |
0.00% |
Bicycle Therapeutics Plc |
25.72 |
0.00% |
0.01% |
0.00% |
Novan Inc |
24.92 |
0.00% |
0.00% |
0.01% |
Abcellera Biologics Inc |
23.11 |
0.00% |
0.00% |
0.00% |
Vir Biotechnology Inc |
20.86 |
0.00% |
0.00% |
0.01% |
Cytokinetics Incorporated |
19.22 |
0.00% |
0.00% |
0.01% |
Aclaris Therapeutics Inc |
17.78 |
0.00% |
0.00% |
0.01% |
Avalo Therapeutics Inc |
17.38 |
0.00% |
0.00% |
0.00% |
Medicure Inc |
16.78 |
0.00% |
0.00% |
0.00% |
Iterum Therapeutics Plc |
14.32 |
0.00% |
0.00% |
0.00% |
Xenon Pharmaceuticals Inc |
13.17 |
0.00% |
0.00% |
0.00% |
Janux Therapeutics Inc |
13.05 |
0.00% |
0.00% |
0.00% |
Aptevo Therapeutics Inc |
12.99 |
0.00% |
0.00% |
0.00% |
Kalvista Pharmaceuticals Inc |
12.69 |
0.00% |
0.00% |
0.00% |
Immunome Inc |
12.51 |
0.00% |
0.00% |
0.00% |
Nuvation Bio Inc |
10.79 |
0.00% |
0.00% |
0.00% |
Fulcrum Therapeutics Inc |
10.72 |
0.00% |
0.00% |
0.00% |
Xilio Therapeutics inc |
9.27 |
0.00% |
0.00% |
0.00% |
Xbiotech Inc |
8.21 |
0.00% |
0.00% |
0.00% |
Inovio Pharmaceuticals Inc |
8.14 |
0.00% |
0.00% |
0.00% |
Pulmatrix Inc |
7.81 |
0.00% |
0.00% |
0.00% |
Dianthus Therapeutics Inc |
6.52 |
0.00% |
0.00% |
0.00% |
Spyre Therapeutics Inc |
5.81 |
0.00% |
0.00% |
0.00% |
Kala Bio inc |
5.75 |
0.00% |
0.00% |
0.00% |
Vtv Therapeutics Inc |
5.02 |
0.00% |
0.00% |
0.00% |
Qualigen Therapeutics Inc |
4.79 |
0.00% |
0.00% |
0.00% |
Ngm Biopharmaceuticals Inc |
4.42 |
0.00% |
0.00% |
0.00% |
Matinas Biopharma Holdings Inc |
4.28 |
0.00% |
0.00% |
0.00% |
Prometheus Biosciences Inc |
4.00 |
0.00% |
0.00% |
0.00% |
Clearside Biomedical Inc |
3.76 |
0.00% |
0.00% |
0.00% |
Dmk Pharmaceuticals Corporation |
3.53 |
0.00% |
0.00% |
0.00% |
Xenetic Biosciences Inc |
2.58 |
0.00% |
0.00% |
0.00% |
Infinity Pharmaceuticals Inc |
2.57 |
0.00% |
0.00% |
0.00% |
Palatin Technologies Inc |
2.18 |
0.00% |
0.00% |
0.00% |
Galmed Pharmaceuticals Ltd |
2.04 |
0.00% |
0.00% |
0.00% |
Cocrystal Pharma Inc |
2.01 |
0.00% |
0.00% |
0.00% |
Humanigen Inc |
1.70 |
0.00% |
0.00% |
0.00% |
Hcw Biologics Inc |
1.45 |
0.00% |
0.00% |
0.00% |
An2 Therapeutics Inc |
1.35 |
0.00% |
0.00% |
0.00% |
Comera Life Sciences Holdings Inc |
1.10 |
0.00% |
0.00% |
0.00% |
Oculis Holding Ag |
0.88 |
0.00% |
0.00% |
0.00% |
Imunon Inc |
0.50 |
0.00% |
0.00% |
0.00% |
Applied Therapeutics Inc |
0.46 |
0.00% |
0.00% |
0.00% |
Geovax Labs Inc |
0.36 |
0.00% |
0.00% |
0.00% |
Altamira Therapeutics Ltd |
0.31 |
0.00% |
0.00% |
0.00% |
Oragenics Inc |
0.22 |
0.00% |
0.00% |
0.00% |
Adagene Inc |
0.10 |
0.00% |
0.00% |
0.00% |
Sangui Biotech International Inc |
0.08 |
0.00% |
0.00% |
0.00% |
Innovation1 Biotech Inc |
0.08 |
0.00% |
0.00% |
0.00% |
Inflarx N v |
0.07 |
0.00% |
0.00% |
0.00% |
Cormedix Inc |
0.07 |
0.00% |
0.02% |
0.01% |
Nascent Biotech Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Akari Therapeutics Plc |
0.00 |
0.00% |
0.00% |
0.00% |
Aldeyra Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Allakos Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Annexon Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Apexigen Inc |
0.00 |
0.00% |
0.00% |
0.00% |
180 Life Sciences Corp |
0.00 |
0.00% |
0.00% |
0.00% |
Astria Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Arrivent Biopharma inc |
0.00 |
0.00% |
0.00% |
0.00% |
Azitra Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Atreca inc |
0.00 |
0.00% |
0.00% |
0.00% |
Biovie Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Belite Bio Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Biostax Corp |
0.00 |
0.00% |
0.00% |
0.00% |
Calcimedica Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Contrafect Corporation |
0.00 |
0.00% |
0.00% |
0.00% |
Cellectar Biosciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Centessa Pharmaceuticals Plc |
0.00 |
0.00% |
0.00% |
0.00% |
Connect Biopharma Holdings Limited |
0.00 |
0.00% |
0.00% |
0.02% |
Contineum Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Cohbar Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Cytodyn inc |
0.00 |
0.00% |
0.00% |
0.00% |
Dice Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Diamedica Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Edesa Biotech Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Eledon Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Eqrx Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Evelo Biosciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Forte Biosciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Galecto Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Genelux Corporation |
0.00 |
0.00% |
0.00% |
0.00% |
Structure Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Gri Bio Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Gt Biopharma Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Indaptus Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Disc Medicine Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Iveric Bio Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Kezar Life Sciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Lianbio |
0.00 |
0.00% |
0.00% |
0.00% |
Merrimack Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Moleculin Biotech Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Mira Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Moonlake Immunotherapeutics |
0.00 |
0.00% |
0.00% |
0.00% |
Mineralys Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Nexien Biopharma Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Beigene Ltd |
0.00 |
0.00% |
0.73% |
0.00% |
Os Therapies Incoporated |
0.00 |
0.00% |
0.00% |
0.00% |
Protokinetix Incorporated |
0.00 |
0.00% |
0.00% |
0.00% |
Prelude Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Palvella Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Pyxis Oncology Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Renovaro Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Transcode Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Renovorx Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Acelyrin Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Third Harmonic Bio Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Tiziana Life Sciences Ltd |
0.00 |
0.00% |
0.00% |
0.00% |
Vera Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Viracta Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Xtl Biopharmaceuticals Ltd |
0.00 |
0.00% |
0.00% |
0.00% |
Zyversa Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Abivax Sa |
0.00 |
0.00% |
0.00% |
0.00% |
Acurx Pharmaceuticals inc |
0.00 |
0.00% |
0.00% |
0.00% |
Atea Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Globestar Therapeutics Corporation |
0.00 |
0.00% |
0.00% |
0.00% |
Pardes Biosciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Shuttle Pharmaceuticals Holdings Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Sellas Life Sciences Group Inc |
-0.28 |
0.00% |
0.00% |
0.00% |
SUBTOTAL |
632,081.79 |
100% |
152,821.81 |
100% |
NNVC's Market share relative to its competitors, as of Q1 2025 within the Major Pharmaceutical Preparations Industry
NNVC's Market share relative to its competitors, as of Q1 2025 within the Healthcare Sector
Note: Market share is calculated based on total revenue. To get a more accurate picture of Nanoviricides inc's market divisions, geographic dispersion, segments, products, and services, visit
Nanoviricides inc's Business Segment.
The list includes publicly traded companies only. More information about the sources of this report can be found
here.